Treace Medical Concepts, Inc. (TMCI) has a consensus analyst rating of Hold, based on 9 analysts covering the stock. Of those, 2 recommend buying, 6 recommend holding, and 1 recommend selling.
The analyst consensus price target for TMCI is $3.00, representing a +34.5% upside from the current price of $2.23. Price targets range from a low of $3.00 to a high of $3.00.
